Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
First Bight Ventures invests in early-stage synthetic biology companies across industrial and pharmaceutical applications. It focuses on enabling scaling of biological manufacturing processes and developing commercial viability through industry engagement.
The firm has made at least six investments since its founding in 2021, including recent seed rounds for Industrial Microbes and Visolis.
No clinical results are reported for the firm itself.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on First Bight Ventures.